Compounds > podophyllotoxin
Page last updated: 2024-08-21

podophyllotoxin and ENT Diseases

podophyllotoxin has been researched along with ENT Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lipozencić, M; Padovan, I1
Lipozencić, M; Padovan, I; Sipus, N1

Other Studies

2 other study(ies) available for podophyllotoxin and ENT Diseases

ArticleYear
[Cytostatic therapy of metastatic and advanced malignant tumors of the ENT region with podophyllin derivatives (SPI-SPG)].
    Radovi Medicinskog faculteta u Zagrebu, 1965, Volume: 13, Issue:1

    Topics: Humans; Neoplasms; Otorhinolaryngologic Diseases; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum

1965
[Submicroscopic changes in human cancer cells under the effect of SP-I and SP-G "Sandoz"].
    Oncology, 1966, Volume: 20, Issue:4

    Topics: Aged; Antineoplastic Agents; Female; Humans; Male; Microscopy, Electron; Middle Aged; Neoplasms; Otorhinolaryngologic Diseases; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum

1966